Recruiting Diabetic Retinopathy Studies in Los Angeles
About Diabetic Retinopathy Clinical Trials in Los Angeles
Diabetic retinopathy is a diabetes complication that affects the blood vessels in the retina and is the leading cause of blindness in working-age adults. Diabetic macular edema (DME) involves fluid accumulation in the macula. Treatment includes anti-VEGF injections, laser therapy, and blood sugar control.
There are currently 1 diabetic retinopathy clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 634 participants. Research is being sponsored by Hoffmann-La Roche. Clinical trial participation is free and participants receive study-related medical care at no cost.
Diabetic Retinopathy Clinical Trials in Los Angeles — FAQ
Are there diabetic retinopathy clinical trials in Los Angeles?
Yes, there are 1 diabetic retinopathy clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Los Angeles?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.
Are clinical trials in Los Angeles free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.
What diabetic retinopathy treatments are being tested?
The 1 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for diabetic retinopathy.
Data updated March 2, 2026 from ClinicalTrials.gov